TY  - GEN
AU  - Amagai,Yosuke
AU  - Matsumoto,Mitsunobu
AU  - Hojo,Kanji
AU  - Iguchi,Motofumi
AU  - Wada,Tooru
AU  - Tanaka,Hidekazu
AU  - Ide,Nobuyuki
AU  - Kato,Akira
AU  - Shichijo,Michitaka
AU  - Abe,Kenji
TI  - Combination therapy of interleukin-2 and sorafenib improves survival benefits and prevents spontaneous pulmonary metastasis in murine renal cell carcinoma models
SN  - 1465-3621
PY  - 2010///0615
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Benzenesulfonates
KW  - administration & dosage
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cell Line, Tumor
KW  - Female
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - Lung Neoplasms
KW  - mortality
KW  - Mice
KW  - Mice, Inbred BALB C
KW  - Nephrectomy
KW  - Niacinamide
KW  - analogs & derivatives
KW  - Phenylurea Compounds
KW  - Pyridines
KW  - Recombinant Proteins
KW  - Sorafenib
KW  - Survival Rate
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1093/jjco/hyp200
ER  -